Nuveen Asset Management, LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 79 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$62,428
-83.7%
27,623
-84.4%
0.00%
Q1 2021$384,000
-7.2%
177,035
-4.2%
0.00%
Q4 2020$414,000
-14.8%
184,851
+1.6%
0.00%
Q3 2020$486,000
-12.6%
181,886
-0.0%
0.00%
Q2 2020$556,000
+118.0%
181,943
+39.9%
0.00%
Q1 2020$255,000
-16.9%
130,022
+21.2%
0.00%
Q4 2019$307,000
-31.6%
107,272
-12.2%
0.00%
Q3 2019$449,000
+33.6%
122,214
+51.0%
0.00%
Q2 2019$336,00080,9630.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Benchmark Capital Advisors 221,700$1,051,0000.83%
EAM Global Investors LLC 227,063$1,076,0000.56%
EAM Investors, LLC 319,187$1,513,0000.25%
COURAGE CAPITAL MANAGEMENT LLC 30,000$142,0000.11%
Cutter & CO Brokerage, Inc. 53,600$254,0000.10%
SABBY MANAGEMENT, LLC 286,800$1,360,0000.08%
D.A. DAVIDSON & CO. 731,300$3,466,0000.07%
Tibra Equities Europe Ltd 63,414$301,0000.05%
Advisor Group, Inc. 556,377$2,637,0000.04%
Laurel Wealth Advisors, Inc. 21,400$101,0000.03%
View complete list of GALECTIN THERAPEUTICS INC shareholders